Get the Stockscreener App
4.01
2.82%
0.11
After Hours:
4.03
0.02
+0.50%
Myomo Inc stock is traded at $4.01, with a volume of 84,555.
It is up +2.82% in the last 24 hours and down -10.49% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$3.90
Open:
$3.86
24h Volume:
84,555
Relative Volume:
0.20
Market Cap:
$116.07M
Revenue:
$19.24M
Net Income/Loss:
$-8.15M
P/E Ratio:
-4.7738
EPS:
-0.84
Net Cash Flow:
$-6.32M
1W Performance:
+4.43%
1M Performance:
-10.49%
6M Performance:
+22.63%
1Y Performance:
+261.26%
1-Day Range:
$3.80
$4.04
1-Week Range:
$3.70
$4.04
52-Week Range:
$0.96
$5.64
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
Myomo Inc Stock (MYO) Latest News
Myomo, Inc. (NYSEAMERICAN:MYO) Shares Acquired by Herr Investment Group LLC - MarketBeat
Stocks of Moelis & Co (MC) are poised to climb above their peers - SETE News
MBX Biosciences director buys $12 million in company stock By Investing.com - Investing.com South Africa
OrbiMed executives purchase $12 million of MBX Biosciences stock - Investing.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AGMYNA - PR Newswire
Kenya’s Most Funded Fintech M-Kopa Fined KSh 885.87 Million in Taxes in Jurisdiction Dispute - Kenyan Wallstreet
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly - Business Wire
Robotics for Physical Therapy Market 2024 Key Vendors – AlterG, Bionik, Ekso Bionics, Myomo - Cauverynews
Medical Wearable Robotic Market 2024 Industry Scenario – Bionik, Ekso Bionics, Myomo, Hocoma - Cauverynews
Myomo executive sells over $8k in company stock - Investing.com
Myomo executive sells over $8k in company stock - Investing.com India
Myomo to Participate in Two Investor Conferences in September - Business Wire
Myomo executive sells over $8k in company stock By Investing.com - Investing.com Canada
Myomo Inc [MYO] Officer makes an insider purchase of 139 shares worth 541.0. - Knox Daily
Analyzing Myomo Inc (MYO) After Recent Trading Activity - Knox Daily
Myomo (MYO) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Myomo: Intriguing Prospects, But Preferable To Wait For A Further Pullback In The Price - Seeking Alpha
Ascendiant Capital Markets Boosts Myomo (NYSEAMERICAN:MYO) Price Target to $8.50 - MarketBeat
Ascendiant Capital Markets Raises Myomo (NYSEAMERICAN:MYO) Price Target to $8.50 - Defense World
The Analyst Verdict: Myomo In The Eyes Of 4 Experts - Benzinga
Myomo (MYO) 3-Year EBITDA Growth Rate : 57.00% (As of Jun. 2024) - GuruFocus.com
Q3 2024 Earnings Forecast for Myomo, Inc. (NYSEAMERICAN:MYO) Issued By HC Wainwright - MarketBeat
Q3 2024 Earnings Forecast for Myomo, Inc. (NYSEAMERICAN:MYO) Issued By HC Wainwright - Defense World
Myomo Inc (MYO) rating initates by Craig Hallum - Knox Daily
HC Wainwright Analysts Boost Earnings Estimates for Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
Q4 2024 EPS Estimates for Myomo, Inc. Boosted by Analyst (NYSEAMERICAN:MYO) - Defense World
Myomo secures new headquarters in Burlington - Investing.com
H.C. Wainwright lifts Myomo price target, maintains Buy rating - Investing.com
H.C. Wainwright lifts Myomo price target, maintains Buy rating - Investing.com India
HC Wainwright Increases Myomo (NYSEAMERICAN:MYO) Price Target to $7.50 - MarketBeat
HC Wainwright Boosts Myomo (NYSEAMERICAN:MYO) Price Target to $7.50 - Defense World
Earnings call: Myomo achieves record results in Q2 2024, plans expansion - Investing.com Australia
Myomo, Inc. (AMEX:MYO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Myomo achieves record results in Q2 2024, plans expansion - Investing.com
Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript - Seeking Alpha
Myomo (NYSEAMERICAN:MYO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Defense World
Myomo (NYSEAMERICAN:MYO) Releases Earnings Results - MarketBeat
MYO’s latest rating updates from top analysts. - Knox Daily
Myomo Reports Second Quarter 2024 Financial Results - wallstreet:online
Financial Analysis: Myomo Inc (MYO)’s Ratios Unveil Key Insights - The Dwinnex
Myomo Inc (MYO)’s results reveal risk - US Post News
Myomo Reports Second Quarter 2024 Financial Results - Business Wire
MYOMyomo, Inc. Latest Stock News & Market Updates - StockTitan
Investing in Myomo Inc (MYO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
MYO’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Myomo (NYSEAMERICAN:MYO) Coverage Initiated by Analysts at Craig Hallum - MarketBeat
Myomo Inc [MYO] Investment Guide: What You Need to Know - Knox Daily
Myomo (NYSEAMERICAN:MYO) Research Coverage Started at Craig Hallum - Defense World
Ratio Analysis: Unpacking Myomo Inc (MYO)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Myomo to Report Second Quarter Financial Results on August 6, 2024 - 01Net
Myomo to Report Second Quarter Financial Results on August 6, 2024 - Business Wire
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):